NASDAQ · BTSG
Healthcare · Medical - Healthcare Information Services
$58.84
Up+$0.12 (+0.20%)
Updated Sep 16, 2026, 8:38 PM
SID Score
5.3/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
BTSG closed at $58.84 after 20 trading sessions, down 1.11% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $60.30 | $60.53 | $58.275 | $58.84 | 1.43M |
| Sep 14, 2026 | $57.91 | $60.77 | $57.91 | $60.30 | 3.45M |
| Sep 11, 2026 | $59.045 | $59.90 | $58.075 | $58.73 | 2.49M |
| Sep 10, 2026 | $61.33 | $62.615 | $57.68 | $57.88 | 3.32M |
| Sep 9, 2026 | $62.575 | $62.825 | $60.925 | $61.99 | 1.3M |
| Sep 8, 2026 | $60.73 | $63.03 | $60.69 | $62.56 | 3.21M |
| Sep 4, 2026 | $60.51 | $61.75 | $60.51 | $60.73 | 1.73M |
| Sep 3, 2026 | $60.72 | $61.475 | $58.98 | $61.43 | 2.11M |
| Sep 2, 2026 | $59.16 | $60.58 | $58.97 | $60.25 | 1.77M |
| Sep 1, 2026 | $58.55 | $59.91 | $58.495 | $59.16 | 1.49M |
| Aug 31, 2026 | $58.76 | $59.07 | $57.80 | $58.40 | 1.92M |
| Aug 28, 2026 | $60.54 | $61.31 | $59.04 | $59.13 | 1.51M |
| Aug 27, 2026 | $61.42 | $63.14 | $60.53 | $60.90 | 3.22M |
| Aug 26, 2026 | $57.20 | $61.37 | $56.75 | $61.35 | 2.55M |
| Aug 25, 2026 | $59.55 | $60.18 | $56.43 | $57.23 | 2.6M |
| Aug 24, 2026 | $58.33 | $60.14 | $58.25 | $59.49 | 2.19M |
| Aug 21, 2026 | $59.97 | $60.65 | $58.8001 | $58.87 | 1.52M |
| Aug 20, 2026 | $58.64 | $60.125 | $58.51 | $59.53 | 1.83M |
| Aug 19, 2026 | $60.15 | $60.41 | $58.42 | $59.33 | 2.91M |
| Aug 18, 2026 | $60.00 | $60.8222 | $59.19 | $59.50 | 1.79M |
The latest Smart Investors Daily articles mentioning BTSG.
BTSG research
Company profile and research snapshot.
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | BTIG | Buy | — |
| Aug 3, 2026 | BTIG | Buy | — |
| Jul 14, 2026 | Morgan Stanley | Overweight | — |
| Jul 14, 2026 | Keybanc | Overweight | — |
| Jul 13, 2026 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
Yahoo · Sep 12, 2026
Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically for growth.
Yahoo · Sep 10, 2026
BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.
SeekingAlpha · Sep 10, 2026
BrightSpring Health's premium 34.38x FY1 P/E is justified by strong EBITDA growth and a forward PEG of 0.73x. Find out why BTSG stock is a buy.
SeekingAlpha · Sep 9, 2026
BrightSpring may benefit from the RASONQUE debut. Click for this BTSG stock update and see if it is the right play for you.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BTSG.
